StonvexLoading…
StonvexStonvexStonvexCore line items from ZBIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $10.00M | $5.00M | $50.00M |
Operating Income | $-383.06M | $-163.89M | $-37.15M |
Net Income | $-377.74M | $-156.99M | $-37.12M |
EPS (Diluted) | $-8.44 | $-11.89 | $-24.25 |
Total Assets | $383.64M | $369.97M | $68.18M |
Total Liabilities | $141.50M | $57.51M | $43.81M |
Cash & Equivalents | $110.64M | $319.74M | $56.86M |
Free Cash Flow OCF − CapEx | $-172.35M | $-119.81M | $-30.55M |
Shares Outstanding | 54.49M | 41.79M | 1.58M |